Skip to content

EBITDA margin at other companies

Microsoft logo
MicrosoftMSFT
61.4%+6.1pp
Veeva Systems logo
Veeva SystemsVEEV
45.1%-0.2pp
IQVIA logo
IQVIAIQV
21.2%-1.0pp
Clarivate logo
ClarivateCLVT
35.9%+18.8pp
Health Catalyst logo
Health CatalystHCAT
-65.1%-75.2pp
Teladoc Health logo
Teladoc HealthTDOC
6.1%+3.3pp

Other financials

Income statement

See full
Revenue$55.9M-5.5%
Gross profit$46.6M-5.0%
Operating income-$201.3M-8.9%
Net income-$138.6M-29.3%
EPS (diluted)-$1.32-38.9%

Balance sheet

See full
Cash & equivalents$157.6M+48.6%
Total debt$169.8M-6.0%
Total assets$514.7M-36.3%

Cash flow

See full
Operating cash flow$11.6M-55.6%
CapEx$3.2M-58.4%
Free cash flow$8.4M-54.5%

Valuation

See full
Market cap$87.68M-78.4%
Enterprise value$99.87M-80.2%
P/S0.4×-1.3×

Profitability

See full
Gross margin84.4%+1.0pp
Operating margin-101.1%-42.1pp
Net margin-71.5%-28.2pp
FCF margin12.1%-8.4pp

Returns & leverage

See full
Current ratio1.8×0.0×

Where this comes from

Calculated from Definitive Healthcare Corp.’s reported figures.

Based on trailing twelve months.

The official record: Definitive Healthcare Corp.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Definitive Healthcare Corp.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Definitive Healthcare Corp.'s EBITDA margin?
Definitive Healthcare Corp. (DH) reported EBITDA margin of -99.5% in Q1 2026.
How has Definitive Healthcare Corp.'s EBITDA margin changed year-over-year?
Definitive Healthcare Corp.'s EBITDA margin increased by 71.9% year-over-year, from -353.8% to -99.5%.
What is the long-term trend for Definitive Healthcare Corp.'s EBITDA margin?
Over 5 years (2020 to 2025), Definitive Healthcare Corp.'s EBITDA margin has grown at a 49.5% compound annual growth rate (CAGR), from 12.2% to -91.5%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.